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ABSTRACT
Purpose: To study the protein Fas ligand (FasL) on the expression of apoptosis, using a model of oxidative stress induced by
azoxymethane (AOM), in the crypt of colon in rats. Methods: Wistar rats (n=14) were assigned into two groups: control (n=7) and
AOM (n=7). A single subcutaneous administration of AOM (5mg/kg) or saline solution was performed at the beginning of third
week and after three hours samples of proximal colon were collected. The expression of FasL was quantified (Software ImageLab)
in percentage of areas in the top, base and all crypt. Results were expressed as mean ± sd (Shapiro-Wilks test and t Student test)
(p < 0.05). Results: In the animals of CG there was no significant difference between the FasL expression of the top (10.75±3.33)
and basal (11.14±3.53) colon crypt (p=0.34293740). In the animals of AOM there was no significant difference between the FasL
expression of the top (8.86±4.19) and basal (8.99±4.08) colon crypt (p=0.78486003). In the animals of CG (10.95±3.43) and AOM
(8.92±4.13) there was a significant difference of the FasL expression (p=0.026466821). A significantly decrease on the FasL
expression was observed in the animals of CG (10.75±3.33) and AOM (8.86±4.19) in the top crypt (p=0.00003755*). A significant
decrease was also observed in the animals of CG (11.14±3.53) and AOM (8.99±4.08) in the basal colon crypt (p=0.00000381**).
Conclusion: Azoxymethane induce the oxidative stress and the significantly decrease of FasL expression, although there is no
significant difference between basal and top of colon crypt linked to consumption-activation of Fas ligand.
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RESUMO
Objetivo: Avaliar o marcador de apoptose Fas ligante (FasL) em um modelo de estresse oxidativo induzido pelo azoximetano
(AOM) na cripta de cólon em ratos. Métodos: 14 ratos Wistar foram distribuídos em dois grupos: controle (n=7) e AOM (n=7). A
AOM (5mg/kg) ou solução salina foi aplicada via subcutânea e a coleta de amostras de colo proximal ocorreu 3 horas após. A FasL
foi quantificada pelo percentual de áreas no topo, base e toda a cripta. Os resultados foram submetidos aos testes de Shapiro-Wilks
e t de Student (p < 0,05). Resultados: No grupo GC, não houve diferença significativa entre a expressão da FasL no topo (10,75 ± 3,33)
e base (11,14 ± 3,53) da cripta (p=0,34293740). No grupo AOM não houve diferença significativa entre a expressão da FasL no
topo (8,86 ± 4,19) e base (8,99 ± 4,08)  e cripta (p=0,78486003). No grupo GC (10,95 ± 3,43) e AOM (8,92 ± 4,13), houve uma
diferença significativa da expressão da FasL (p=0,026466821). Redução significativa na expressão da FasL ocorreu nos em GC
(10,75 ± 3,33) e AOM (8,86 ± 4,19) no topo da cripta (p = 0,00003755*). Foi observada diminuição significativa em GC (11,14 ± 3,53)
e AOM (8,99 ± 4,08) na base da cripta (p=0,00000381**). Conclusão: Azoximetano induziu o estresse oxidativo identificado pela
diminuição significativa da expressão da FasL, embora não haja diferença significativa entre a base e parte superior da cripta
associada à ativação de consumo do FasL.
Descritores: Proteína Ligante Fas. Azoximetano. Estresse Oxidativo. Apoptose. Ratos
1Research performed at the Surgery and Experimentation Postgraduate Program, Federal University of Sao Paulo (UNIFESP) and Experimental
Carcinogenesis Laboratory of the Central Animal Facilities, Federal University of Mato Grosso do Sul (UFMS), Campo Grande-MS, Brazil.
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Introduction
Programmed cell death, apoptosis, is known to participate
in biological processes of development, maintenance of tissue
homeostasis and elimination of cancer cells. Malfunctions of
apoptosis have been implicated in many forms of human diseases.
Apoptosis may be caused by various inducers such as chemical
compounds or proteins. The biochemical pathways of apoptosis
are complex and depend on both the cells and the inducers. It
involves receptor-mediated protease activation, cytolytic plasma
protein interactions, and ultimately distinct morphological
alterations. These alterations can be observed microscopically and
include DNA degradation and margination, condensation of
chromatin, cell membrane alterations and the formation of
apoptotic cascade1,2.
The Fas protein and Fas ligand (FasL) are two proteins
that interact to activate one of the best defined apoptotic
pathways. Fas and FasL are both members of the TNF (Tumor
Necrosis Factor) family. The Fas is part of the transmembrane
receptor family and the FasL is part of the membrane-associated
cytokine family. The binding of Fas ligand with its receptor
induces apoptosis. The Fas ligand-receptor interactions play an
important role in the regulation of the immune system and the
progression of cancer. Over expression of the FAS ligand on the
cell surface has been shown to cause shedding of the protein, and
the soluble form of the FAS ligand can actively trigger apoptosis
by binding to FAS3,4.
There are strong evidences that the stem-cell population
is concentrated at the base of the colon crypt, within the stem-cell
niche formed by the stem cells themselves and mesenchymal cells
that surround the crypt base5-8. Apoptosis marker positive cells
were found mainly on the luminal epithelium of the normal colon
and were present in crypts of the colon, in addition to the luminal
epithelium, in pathological situations such as ulcerative colitis and
colorectal adenomas5-9. The use of these apoptosis marker to
monitor the beneficial effects of chemopreventative interventions
would be to reduce the development of colorectal cancer within
the context of clinical trials5-8.
Given the increasing evidence that apoptosis may play
a role either in the induction or propagation of neoplastic
transformation, we undertook to develop a model to examine FasL
interaction in colonic mucosa layer. Thus, our aim was investigate
the role of azoxymethane, a well known oxidative stress inducer
compound, in modulating the biomarker FasL in the colon crypt
of rats.
Methods
Animals and facilities
The experimental protocol was approved by the Ethics
Committee of the Federal University of Sao Paulo (#0183/06) and
ratified by animal Ethics Committee of Federal University of
Mato Grosso do Sul (#064/04). The rats were kept according to
the norms of the Guide for the Care and Use of Laboratory
Animals (Institute for Laboratory Animal Research, 1996) and
to the ethical principles of the Brazilian Committee on Animal
Experimentation (COBEA). It was designed as an experimental,
randomized, controlled trial with blind assessment of the outcome.
Fourteen male Wistar rats, weight 280-320g), were housed
in temperature (22oC±3oC), light-controlled environmental
conditions with a 12-hour light-dark cycle (130 to 325 lux),
humidity of 58±13%, and given free access to water and standard
pellet chow. All procedures were done in the laboratories of
Experimental Carcinogenesis of the Central Animal Facilities
(UFMS) and follow the guide of Toxics Drugs Manipulation.
Experimental design
The animals were randomly assigned into one of the
two groups: Control group (CG/n=7) and Azoxymethane group
(AOM /n=7). Tail tattoos, made with an indelible black ink
pen, were used to identify groups (CG and AOM) and individual
animals (1 to 7) within each group.
Drugs administration
During two weeks the animals were acclimated to
laboratory environment and observed the bodyweight curve.
At the beginning of third week the azoxymethane (AOM -
C2H6N2O. Sigma, cat. A9517, lot 014K0719) was administered
subcutaneously (5 mg/kg) to the animals of AOM group and
to the animals of control group were given 0.9% saline solution
subcutaneously (10 ml/kg). The volumes of both drugs were
equivalents.
Colon samples collecting and euthanasia
At the end of the third hours, under intraperitoneal
thiopental (40 mg/kg) anesthesia, it was performed a midline
laparotomy, identified the terminal ileum and ascendant colon
and excised en bloc. The euthanasia occurred by overdose of
thiopental (150mg/kg) until cardio respiratory arrest.
Histological processing
The intestine samples were incised along the
antimesenteric border and the mucosa was washed with Ringer
solution until removed all the macroscopic intestinal residues. A
1-cm long segment was resected from the ascendant colon. The
segment of colon wall was sandwiched between the two plates of
a hinged perforated double holder in order to be maintained
straightened, and the set was immersed in 10% buffered
formaldehyde solution for 24 hours. Each sample was embedded
in paraffin (with sample identification being preserved) and
sectioned with a microtome (2-micrometer-thick sagital sections
of colon wall). The sections were fixed on silanized glass slides.
Immunohistochemistry procedure
The colon was prepared with biological marker Fas Ligant
(FasL, termination epitope – N20, cat. Santa Cruz, SC834
product, lot E2804; 1:100 dilution) and followed by secondary
antibody anti-rat (Dako LSABTM, K609 product, lot 15068);
revealer of color DAB (diaminobenzidine, DakoTM, K3468
product, lot 01317, in 1:10 dilution); FasL expression was obtained
as brown color areas.
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Image capture and processing
Optical microscopy evaluation was performed with a
microscope (NikonTM, mod. Elipse E200) equipped with 10X
binocular lenses and a 40X/0.65 objective. The microscope was
coupled to a video camera (SamsungTM, mod. SCC131) connected
to a microcomputer (DuronTM 750-MHz processor, 128-MB RAM,
FIGURE 1 - Representative photomicrography of FasL expression (right side) and the blue
label marks (lest side) using a RGB filter (circle). (Immunohistochemical - 40x)
FasL quantification
FasL was quantified by computer-assisted image
processing with Image LabTM software. Twenty single images
from each sample were captured, always centered on the crypt.
The optimized image crypts were randomly captured saved and
FIGURE 2 - FasL quantified by computer-assisted image processing with Image LabTM software. The
quantified brown coloration density corresponds to FasL expression in percentage area (using a RGB
filter, blue background, 0-to-147 color interval) in the selected crypt. (Immunohistochemical - 400X)

20-GB hard disk, Microsoft WindowsTM 98 SE) through a video
board (Pinnacle StudioTM PCTV, USB). The captured image was
saved in individual archives with previous codification. All
archives were submitted for optimization of the photographic
quality with use of Adobe PhotoshopTM Software 7.0 / image /
adjusted / canal RGB / curves / automatic (Figure 1).
codified scheme. The quantified brown coloration density
corresponds to FasL expression in percentage area (using a RGB
filter, blue background, 0-to-147 color interval) in the selected crypt.
All histological analyses were performed by a single pathologist
blinded to the origin of the groups (Figure 2).
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Statistical analysis
Parametric results were expressed as mean ± standard
deviation and Shapiro-Wilks test was performed to check the
normality of the data before running the t student test (Statistical
program Epi-InfoTM and BioEstatTM). A 95% confidence interval
and a 5% significance level (p < 0.05) were adopted.
Results
The means and standard deviation of the percentage area
(µm2) of biomarker FasL in the colon crypt (entire, top and basal)
in CG and AOM were showed on the Table 1.
The statistical significance (p<0.05) among the basal, top
TABLE 1 - Immunohistochemical expression of the percentage area (µm) of biomarker FasL in the colon
crypt (entire, top and basal) in CG and AOM
 CG AOM 
Crypt Top Basal Crypt Top Basal 
Mean±Sd 10.95±3.43 10.75±3.33 11.14±3.53 8.92±4.13 8.86±4.19 8.99±4.08 
and entire colon crypt were showed in the Table 2. In the animals
of CG there was no significant difference between the FasL
expression of the top (10.75±3.33) and basal (11.14±3.53) colon
crypt (p=0.34293740). In the animals of AOM there was no
significant difference between the FasL expression of the top
(8.86±4.19) and basal (8.99±4.08) colon crypt (p=0.78486003).
In the animals of CG (10.95±3.43) and AOM (8.92±4.13) there
was no significant difference of the FasL expression
(p=0.026466821). A significantly decrease on the FasL
expression was observed in the animals of CG (10.75±3.33) and
AOM (8.86±4.19) in the top crypt (p=0.00003755*). A
significantly decrease was also observed in the animals of CG
(11.14±3.53) and AOM (8.99±4.08) in the basal colon crypt
(p=0.00000381**).
TABLE 2 - The statistical significance of percentage area among entire, top and basal colon
crypt in the CG and AOM. The t student test and Shapiro-Wilks test (p<0.05)
Control (Top crypt) X  (Basal crypt)      p = 0.34293740 
AOM  (Top crypt) X  (Basal crypt)    p = 0.78486003 
Control (Top crypt)  X  AOM (Top crypt)      p = 0.00003755* 
Control (Basal crypt) X AOM (Basal crypt)      p = 0.00000381** 
Control (Entire crypt) X AOM (Entire crypt)     p= 0.026466821*** 
Discussion
The role of apoptosis, or programmed cell death, in the
development of colon neoplasia has received increasing interest
as techniques for studying the signaling pathways and genetics of
this process have been developed. The mechanism of apoptotic
cell death is complex9. It involves receptor-mediated protease
activation, cytolytic plasma protein interactions, and ultimately
distinct morphological alterations. These alterations can be
observed microscopically and include DNA degradation and
margination, condensation of chromatin, cell membrane alterations
and the formation of apoptotic cascade9,10.
The azoxymethane is well known as inductor of
oxidative stress and promote the appearance of aberrant crypt foci
(ACF). The AOM-induced ACF assays have been extensively used
as an endpoint in short-term carcinogenesis and chemoprevention
studies11,12. In previous reports we demonstrated the association
of AOM and the occurrence of ACF in a rat model. In this
research we used the similar model to induce the oxidative
stress13-15.
Apoptosis is a central feature of the regulation of
colonic epithelial cell numbers. Currently, the mechanisms and
control of apoptosis in colonic epithelial cell turnover are poorly
understood16,17.
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Acquisition of resistance to apoptosis is thought to be
crucial in the transformation of cells from normal to neoplastic in
many tissues. A functional apoptotic pathway appears to be
essential to maintain low numbers of mutated cells. Cells that have
acquired resistances to apoptosis either before or as a result of
mutational changes fail to be eliminated by apoptosis, and are in
this way able to continue the progression towards a neoplastic
phenotype15-21. Failure of apoptosis may be of particular
importance in the development of colorectal cancer15,22-24.
There is in vitro and in vivo evidence that colon cancer
cells are resistant to apoptosis mediated by Fas. Despite
intracellular defects in Fas signalling in colon cancer cells, the
Fas receptor is downregulated in many colonic carcinomas. Fas
downregulation might be a consequence of p53 mutation at later
stages of colon tumour development because Fas is a target gene
for transcriptional activation by p53. Transfection of wild-type
p53 into various tumour cell lines has been shown to restore/
upregulate Fas expression22-24.
The Fas (CD95/APO-1) receptor (Fas) is a cell surface
receptor that mediates apoptotic cell death upon triggering by
Fas ligand (FasL). The Fas is widely expressed in most cell types,
including epithelial cells, and Fas mediated apoptosis may be
involved in cell turnover in many tissues. The FasL also contributes
to immune privilege in certain tissues where it is expressed, by
triggering the apoptosis of infiltrating inflammatory cells15,25-27.
The Fas is expressed in normal colonic epithelium, and
normal colonic epithelial cells are relatively sensitive to Fas
mediated apoptosis. Whereas Fas is downregulated in a proportion
of colonic adenocarcinomas, FasL is upregulated in most colon
tumour. Coexpression of Fas and FasL occurs throughout large
areas of colon tumour, yet this does not lead to increased apoptosis
of the tumour cells. This is in agreement with the finding that the
Fas expressed in colon carcinoma cell lines fails to transduce an
apoptotic signal upon engagement with FasL26-28.
In an attempt to ascertain the significance and elucidate
the underlying mechanism of Fas up-regulation in vivo, studies
suggest that most low Fas-expressing (LF–) tumour up-regulate
their surface Fas expression.
Given the evidence that apoptosis may play a role either
in the induction or propagation of neoplastic transformation,
we undertook to develop a model in which to examine FasL in
aberrant colon crypts of rats.
The pattern of FasL immunoreactivity in normal
epithelium was associate to the FasL expression occurring in
epithelial cells at the luminal surface, but being absent from
the crypt base. FasL expression by normal colonic epithelium and
hyperplastic polyps was restricted to the luminal surface, where
expression coincides with epithelial apoptosis15.
Stem cells participate actively in tumour origin by
current concepts. In colon stem cells are located at the base of the
crypts. However, in the tumorigenesis dysplastic cells are located
at the apex of the crypts and luminal surface, a situation that
generates controversy. We proposed to study the apoptosis in the
base and apex of the crypt of colon with the biomarker-Fas ligand
participating in an early stage and prior to the morphologic
cellular changes, thus allowing to identify the activation of
apoptosis in apex-base of the crypt and thus quantify the
stimulation induces apoptosis in the crypt15,29.
Our data demonstrated a significantly higher expression
of FasL in the control animals without the stress inductor
compared at the AOM group (Table 1). The low-FasL expression
may be associated with an upregulated Fas expression as was
reported by other authors. This may explain the higher incidence
of apoptosis in this area as the model shown in other studies.
On the other hand we fail in to identify a difference of FasL
expression between the base and the top of crypt in the control
animals (Table 2), as was related by the literature for the Fas
expression. In the animals of AOM, although the expression of
FasL is also lower than that presented by the control group, no
significant difference between the values of FasL expressed on
the top or bottom of the crypt.
Since the Fas receptor is a cell surface receptor that
mediates apoptotic cell death upon triggering by FasL and it is
down-expressed, it is assumed that the AOM induced an increase
of apoptosis independent of being top or bottom of the crypt.
Further investigations should be conducted to establish
the exact role of FasL as a mediator of the expression of Fas and
consequently apoptosis. The research has important limiting
factor as the model of early induction of apoptosis by AOM,
although it is also widely employed in experimental models; it
is well known, from samples of polyps and adenomas, that
human behavior are different from experimental models in the
expression of biomarkers. Either way, the findings raise an
important question about the lack of differential expression of
FasL between bottom and top of the crypt. However, it would
be interesting that the concomitant expression of the Fas was
investigated.
Conclusion
Our data suggest that AOM induced the oxidative stress
identified by the significantly decrease of FasL expression,
although there is no significant difference between basal and top
of colon crypt linked to consumption-activation of Fas ligand,
in both control or AOM groups.
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